Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
305 hedge funds and large institutions have $5.1B invested in Abiomed Inc in 2016 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 107 increasing their positions, 114 reducing their positions, and 35 closing their positions.
37% more call options, than puts
Call options by funds: $29M | Put options by funds: $21.1M
26% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 35
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
12% more capital invested
Capital invested by funds: $4.54B → $5.1B (+$554M)
3% more funds holding
Funds holding: 297 → 305 (+8)
6% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 114
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$61.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.4M |
| 3 |
D.E. Shaw & Co
New York
|
+$36.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$35.8M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$28.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$134M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$68.3M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$36.9M |
| 4 |
Primecap Management
Pasadena,
California
|
-$35.7M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$25.3M |
ABMD Hedge Fund Activity: Q3 2016 in Review
305 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2016, worth a combined $5.1B — up 12% from $4.54B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new ABMD positions and 35 closed out — a net gain of 9 holders — while 107 added to existing stakes and 114 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $61.5M. The largest seller was Macquarie Group, cutting an estimated $134M.
- 305 institutional investors held Abiomed Inc (ABMD) as of Q3 2016, up from 297 in Q2 2016.
- Funds reported $5.1B of Abiomed Inc stock for Q3 2016, up 12% quarter-over-quarter.
- 44 funds opened new Abiomed Inc positions in Q3 2016 and 35 closed out, a net change of +9 holders.
- The largest Abiomed Inc buyer in Q3 2016 was Wellington Management Group, an estimated $61.5M added.
- The largest Abiomed Inc seller in Q3 2016 was Macquarie Group, an estimated $134M sold.
Based on aggregated 13F filings for Q3 2016.